To access this element change to forms mode OFF
Grant Award View - GA276513
Understanding and targeting self-renewal in aggressive blood cancers
GA ID:
GA276513
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
27-Oct-2022
Publish Date:
19-Dec-2022
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2026
Value (AUD):
$976,222.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Understanding and targeting self-renewal in aggressive blood cancers
Purpose:
The epigenetic protein Menin, is critical for the ability of leukaemia cells to divide indefinitely. Therapies that target this protein are currently in clinical trials, however it is unclear how they work. By studying how resistance to these therapies emerges, we have unexpectedly discovered that they work differently to what was previously thought. This proposal will use new tools to elucidate these findings in order to develop ways to overcome resistance and improve their efficacy.
GO ID:
GO Title:
Ideas Grants 2022
Internal Reference ID:
2022/GNT2021063
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED STATES